$256M
51-100
Powerful, Off-the-Shelf Cell Therapies Made Accessible. We are transforming cancer treatment with first-in-class cell therapies, with enhanced and targeted potency, improved safety and broad applicability across hematologic and solid tumor cancers.
City Rank
Share
2nd
In Taipei City
out of 155 startups
National Rank
Share
2nd
In Taiwan
out of 217 startups
Regional Rank
Share
118th
In East Asia
out of 2082 startups
City Rank
Share
1st
In Taipei City
out of 53 startups
National Rank
Share
1st
In Taiwan
out of 78 startups
Regional Rank
Share
46th
In East Asia
out of 820 startups
rankings by:
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...